-transparent.png){kind=logo}
We wish to report strong lymphocyte crossmatch incompatibility attributable to anti-Lea antibody. The prospective renal transplant recipient was Le(a-b-) and her serum contained potent anti-Lea and anti-LebH antibodies. Despite the fact that were able to demonstrate greater B lymphocyte than T lymphocyte Lewis(a+) antigenicity, this serum was capable of causing greater than 80% cytotoxicity of Le(a+) and Le(b+)O or A2 whole lymphocyte populations. Antibody activity was completely inhibited by Lewis substance. This inhibition was specific and did not interfere with HLA antibody activity.
Related Publications
B Hudelson, and
J Liu, and
J Ocariz, and
D Martin, and
L M Slater
July 1980,
The Tokai journal of experimental and clinical medicine,
B Hudelson, and
J Liu, and
J Ocariz, and
D Martin, and
L M Slater
November 1974,
Cancer,
B Hudelson, and
J Liu, and
J Ocariz, and
D Martin, and
L M Slater
May 1976,
Transplantation,
B Hudelson, and
J Liu, and
J Ocariz, and
D Martin, and
L M Slater
December 1986,
Changgeng yi xue za zhi,
B Hudelson, and
J Liu, and
J Ocariz, and
D Martin, and
L M Slater
August 1985,
Tissue antigens,
B Hudelson, and
J Liu, and
J Ocariz, and
D Martin, and
L M Slater
November 1975,
The New England journal of medicine,
B Hudelson, and
J Liu, and
J Ocariz, and
D Martin, and
L M Slater
January 1975,
Vox sanguinis,
B Hudelson, and
J Liu, and
J Ocariz, and
D Martin, and
L M Slater
February 1979,
Journal of immunology (Baltimore, Md. : 1950),
B Hudelson, and
J Liu, and
J Ocariz, and
D Martin, and
L M Slater
May 1978,
Transplantation,
B Hudelson, and
J Liu, and
J Ocariz, and
D Martin, and
L M Slater
October 1985,
European journal of immunology,
